These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
63. Using Gene Expression Profiling to Personalize Skin Cancer Management. LeQuang JA J Clin Aesthet Dermatol; 2022 Nov; 15(11 Suppl 1):S3-S15. PubMed ID: 36405422 [TBL] [Abstract][Full Text] [Related]
64. Indocyanine Green Fluorescence Imaging with Lymphoscintigraphy for Sentinel Node Biopsy in Melanoma: Increasing the Sentinel Lymph Node-Positive Rate. Knackstedt R; Couto RA; Ko J; Cakmakoglu C; Wu D; Gastman B Ann Surg Oncol; 2019 Oct; 26(11):3550-3560. PubMed ID: 31313036 [TBL] [Abstract][Full Text] [Related]
65. Is sentinel lymph node biopsy of therapeutic relevance for melanoma? Möhrle M; Schippert W; Rassner G; Garbe C; Breuninger H Dermatology; 2004; 209(1):5-13. PubMed ID: 15237261 [TBL] [Abstract][Full Text] [Related]
66. Sentinel lymph node biopsy in cutaneous melanoma of the head and neck using the indocyanine green SPY Elite system. Vahabzadeh-Hagh AM; Blackwell KE; Abemayor E; St John MA Am J Otolaryngol; 2018; 39(5):485-488. PubMed ID: 29803536 [TBL] [Abstract][Full Text] [Related]
67. Prognostic role of sentinel lymph node biopsy for patients with cutaneous melanoma: A retrospective study of surveillance, epidemiology, and end-result population-based data. Chen J; Xu Y; Zhou Y; Wang Y; Zhu H; Shi Y Oncotarget; 2016 Jul; 7(29):45671-45677. PubMed ID: 27344178 [TBL] [Abstract][Full Text] [Related]
68. Sentinel Lymph Node Biopsy for Cutaneous Head and Neck Melanoma: Mapping the Parotid Gland. Picon AI; Coit DG; Shaha AR; Brady MS; Boyle JO; Singh BB; Wong RJ; Busam KJ; Shah JP; Kraus DH Ann Surg Oncol; 2016 Dec; 23(Suppl 5):9001-9009. PubMed ID: 16715435 [TBL] [Abstract][Full Text] [Related]
69. Sentinel Lymph Node Biopsy in Cutaneous Melanoma: Standard and New Technical Procedures and Clinical Advances. A Systematic Review of the Literature. Tardelli E; Mazzarri S; Rubello D; Gennaro M; Fantechi L; Duce V; Romanini A; Chondrogiannis S; Volterrani D; Colletti PM; Manca G Clin Nucl Med; 2016 Dec; 41(12):e498-e507. PubMed ID: 27749418 [TBL] [Abstract][Full Text] [Related]
70. Is it Necessary to Perform Sentinel Lymph Node Biopsy in Thin Melanoma? A Retrospective Single Center Analysis. Kocsis A; Karsko L; Kurgyis Z; Besenyi Z; Pavics L; Dosa-Racz E; Kis E; Baltas E; Ocsai H; Varga E; Bende B; Varga A; Mohos G; Korom I; Varga J; Kemeny L; Nemeth IB; Olah J Pathol Oncol Res; 2020 Jul; 26(3):1861-1868. PubMed ID: 31792874 [TBL] [Abstract][Full Text] [Related]
71. Single-institution experience in the management of patients with clinical stage I and II cutaneous melanoma: results of sentinel lymph node biopsy in 240 cases. Rex J; Paradelo C; Mangas C; Hilari JM; Fernández-Figueras MT; Fraile M; Alastrué A; Ferrándiz C Dermatol Surg; 2005 Nov; 31(11 Pt 1):1385-93. PubMed ID: 16416605 [TBL] [Abstract][Full Text] [Related]
72. The prognostic value of a reverse transcriptase-PCR assay of sentinel lymph node biopsy for patients with cutaneous melanoma: a single-center analysis in Japan. Ito T; Moroi Y; Oba J; Nakahara T; Takeuchi S; Uchi H; Takahara M; Masuda T; Furue M Melanoma Res; 2012 Feb; 22(1):38-44. PubMed ID: 22108607 [TBL] [Abstract][Full Text] [Related]
73. The role of sentinel node tumor burden in modeling the prognosis of melanoma patients with positive sentinel node biopsy: an Italian melanoma intergroup study (N = 2,086). Tropea S; Del Fiore P; Maurichi A; Patuzzo R; Santinami M; Ribero S; Quaglino P; Caliendo V; Borgognoni L; Sestini S; Giudice G; Nacchiero E; Caracò C; Cordova A; Solari N; Piazzalunga D; Tauceri F; Carcoforo P; Lombardo M; Cavallari S; Mocellin S; BMC Cancer; 2022 Jun; 22(1):610. PubMed ID: 35659273 [TBL] [Abstract][Full Text] [Related]
74. Examination of regional lymph nodes by sentinel node biopsy and molecular analysis provides new staging facilities in primary cutaneous melanoma. Blaheta HJ; Ellwanger U; Schittek B; Sotlar K; MacZey E; Breuninger H; Thelen MH; Bueltmann B; Rassner G; Garbe C J Invest Dermatol; 2000 Apr; 114(4):637-42. PubMed ID: 10733666 [TBL] [Abstract][Full Text] [Related]
75. A retrospective, multicenter analysis of the predictive value of mitotic rate for sentinel lymph node (SLN) positivity in thin melanomas. Wat H; Senthilselvan A; Salopek TG J Am Acad Dermatol; 2016 Jan; 74(1):94-101. PubMed ID: 26542815 [TBL] [Abstract][Full Text] [Related]
76. The value of sentinel node mapping for staging melanoma. Dijkstra B; Hill A; Kelly L; Prendegast M; McDermott E; O'Donnell M; Collins C; O'Higgins N Ir Med J; 2001; 94(7):210-2. PubMed ID: 11693212 [TBL] [Abstract][Full Text] [Related]
77. Is sentinel lymph node biopsy the standard of care for cutaneous head and neck melanoma? Schmalbach CE; Bradford CR Laryngoscope; 2015 Jan; 125(1):153-60. PubMed ID: 24986770 [TBL] [Abstract][Full Text] [Related]
78. [Sentinel lymph node biopsy for melanoma: prognostic value and disadvantages in 300 patients]. de Vries M; Jager PL; Suurmeijer AJ; Plukker JT; van Ginkel RJ; Hoekstra HJ Ned Tijdschr Geneeskd; 2005 Aug; 149(33):1845-51. PubMed ID: 16128183 [TBL] [Abstract][Full Text] [Related]
79. Re-evaluation of Sentinel Lymph Node Biopsy for Melanoma. Morrison S; Han D Curr Treat Options Oncol; 2021 Feb; 22(3):22. PubMed ID: 33560505 [TBL] [Abstract][Full Text] [Related]
80. Omission of Completion Lymph Node Dissection in Sentinel Node Biopsy Positive Head and Neck Cutaneous Melanoma Patients. Kesmodel SB; Kronenfeld JP; Zhao W; Koru-Sengul T; Goel N; Weingrad DN; Hernandez-Aya L; Lutzky J; Feun L; Garland-Kledzik M; Crystal JS Ann Surg Oncol; 2023 Nov; 30(12):7671-7685. PubMed ID: 37639029 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]